The future is now: SGLT2 inhibitors and type 1 diabetes - what about exercise?

Publikationen: Beitrag in FachzeitschriftZeitschriftenaufsätzeForschungBegutachtung

Standard

The future is now : SGLT2 inhibitors and type 1 diabetes - what about exercise? / Eckstein, Max L; Freitag, Nils; Schumann, Moritz; Tripolt, Norbert; Hofmann, Peter; Moser, Othmar; Sourij, Harald.

in: Diabetes research and clinical practice, 01.08.2019, S. 107806.

Publikationen: Beitrag in FachzeitschriftZeitschriftenaufsätzeForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{997d168916aa4031982644e835243981,
title = "The future is now: SGLT2 inhibitors and type 1 diabetes - what about exercise?",
author = "Eckstein, {Max L} and Nils Freitag and Moritz Schumann and Norbert Tripolt and Peter Hofmann and Othmar Moser and Harald Sourij",
note = "Online: 01.08.2019",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.diabres.2019.107806",
language = "English",
pages = "107806",
journal = "Diabetes research and clinical practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - The future is now

T2 - SGLT2 inhibitors and type 1 diabetes - what about exercise?

AU - Eckstein, Max L

AU - Freitag, Nils

AU - Schumann, Moritz

AU - Tripolt, Norbert

AU - Hofmann, Peter

AU - Moser, Othmar

AU - Sourij, Harald

N1 - Online: 01.08.2019

PY - 2019/8/1

Y1 - 2019/8/1

U2 - 10.1016/j.diabres.2019.107806

DO - 10.1016/j.diabres.2019.107806

M3 - Journal articles

C2 - 31377225

SP - 107806

JO - Diabetes research and clinical practice

JF - Diabetes research and clinical practice

SN - 0168-8227

ER -

ID: 4449769